Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Medecine Sciences : M/S|September 8, 2025
[Transitioning to adult oncology for adolescents and young adults (AYAs): The experience of an AYA unit]Séverine Chiesa, Natacha Naoun, Fanny Morin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 8, 2023
Contribution of collegial support meetings (CSM) in the management of complex situations of patients with advanced cancerCaroline Poisson, Christine Mateus, Anda Sampetrean, et al.
Journal of Visceral Surgery|February 25, 2025
Contraindication to surgery in primary retroperitoneal sarcoma: Retrospective series on 20years of practice in a high-volume sarcoma centerBelkacem Acidi, Matthieu Faron, Olivier Mir, et al.
Cancer Treatment Reviews|February 28, 2025
Therapeutic advances in Tenosynovial giant cell Tumor: Targeting the CSF1/CSF1R axisTarek Assi, Tania Moussa, Carine Ngo, et al.
Radiation Oncology (London, England)|April 21, 2022
Favorable safety profile of moderate hypofractionated over normofractionated radiotherapy in breast cancer patients: a multicentric prospective real-life data farming analysisIrfane Issoufaly, Claire Petit, Sébastien Guihard, et al.
BJU International|April 4, 2017
Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancerAlice Clément-Zhao, Marie Auvray, Hail Aboudagga, et al.
Cancer Treatment Reviews|December 30, 2023
Desmoid-type fibromatosis: Current therapeutic strategies and future perspectivesRebecca Ibrahim, Tarek Assi, Rita Khoury, et al.
JCO Precision Oncology|June 7, 2024
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni SyndromeMichele Bottosso, Benjamin Verret, Olivier Caron, et al.
Cancer|September 5, 2025
Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort studyMina Fazel, Romain Varnier, Hélène Vanacker, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2024
HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndromeMichele Bottosso, Renata L Sandoval, Benjamin Verret, et al.
Pageof 5